Kinrix 58160-0812-52
Generic: Diphtheria And Tetanus Toxoids And Acellular Pertussis Adsorbed And Inactivated Poliovirus Vaccine
- Manufacturer
- Glaxosmithkline Biologicals Sa
- Dosage Form
- Injection, Suspension
- Route
- Intramuscular
- Product Type
- Vaccine
- Marketing Start
- July 9, 2008
- Listing Expires
- December 31, 2027
- Application
- BLA125260
Active Ingredients
| Ingredient | Strength |
|---|---|
| Bordetella Pertussis Filamentous Hemagglutinin Antigen (formaldehyde Inactivated) | 25 [iU]/.5mL |
| Bordetella Pertussis Pertactin Antigen (formaldehyde Inactivated) | 8 ug/.5mL |
| Bordetella Pertussis Toxoid Antigen (formaldehyde, Glutaraldehyde Inactivated) | 25 ug/.5mL |
| Clostridium Tetani Toxoid Antigen (formaldehyde Inactivated) | 10 [iU]/.5mL |
| Corynebacterium Diphtheriae Toxoid Antigen (formaldehyde Inactivated) | 25 [iU]/.5mL |
| Poliovirus Type 1 Antigen (formaldehyde Inactivated) | 40 [iU]/.5mL |
| Poliovirus Type 2 Antigen (formaldehyde Inactivated) | 8 [iU]/.5mL |
| Poliovirus Type 3 Antigen (formaldehyde Inactivated) | 32 [iU]/.5mL |
Drug Class
Actively Acquired Immunity [PE]Actively Acquired Immunity [PE]Actively Acquired Immunity [PE]
Selected Package
58160-0812-52Selected10 SYRINGE in 1 CARTON (58160-812-52) / .5 mL in 1 SYRINGE (58160-812-43)